跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARX-Oxycodone/Naloxone oxycodone hydrochloride / naloxone hydrochloride 20/10 mg modified release tablets blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ARX-Oxycodone/Naloxone oxycodone hydrochloride / naloxone hydrochloride 20/10 mg modified release tablets blister pack
Approved
STANDARD
ARX-Oxycodone/Naloxone oxycodone hydrochloride / naloxone hydrochloride 20/10 mg modified release tablets blister pack
Mundipharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
c3729b0629a82396
Company
Mundipharma Pty Ltd
Type
Standard
Approval Details
Approval Id
c3729b0629a82396
Product Name
ARX-Oxycodone/Naloxone oxycodone hydrochloride / naloxone hydrochloride 20/10 mg modified release tablets blister pack
Artg Id
446592
Artg Name
ARX-Oxycodone/Naloxone oxycodone hydrochloride / naloxone hydrochloride 20/10 mg modified release tablets blister pack
Sponsor
Mundipharma Pty Ltd
Company Detail Path
/organization/mundipharma-pty-ltd
Artg Date
2024-10-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2025-CMI-01374-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-PI-02715-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
c3729b0629a82396
Type
Standard
Back to TGA Approvals